Lisa Hopcroft
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, COVID-19 Clinical Research Studies, COVID-19 Impact on Reproduction, Epigenetics and DNA Methylation, COVID-19 and healthcare impacts
Most-Cited Works
- → SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland(2022)295 cited
- → Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells(2016)225 cited
- → Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia(2018)156 cited
- → JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivo(2014)154 cited
- → Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase Inhibition(2016)132 cited
- → Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition(2017)131 cited
- → Inhibition of interleukin-1 signaling enhances elimination of tyrosine kinase inhibitor–treated CML stem cells(2016)108 cited
- → The Antiproliferative Activity of Kinase Inhibitors in Chronic Myeloid Leukemia Cells Is Mediated by FOXO Transcription Factors(2014)89 cited
- → Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT)(2024)86 cited
- → Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study(2022)74 cited